A prospective, single-center, case series study analysing safet and efficacy of Fosravuconazole in severe onychomycosis in the elderly patients
Latest Information Update: 01 Jun 2021
At a glance
- Drugs Fosravuconazole (Primary)
- Indications Onychomycosis
- Focus Adverse reactions; Therapeutic Use
- 01 Jun 2021 New trial record